WCN24-1092 Predictive Value of the Domain Specific PLA2R Antibodies for Clinical Remission in Patients with Primary Membranous Nephropathy

Kezhi Zhou,Junyi Zhou,Leting Zhou,Jing Xue,Bin Liu,Zhijian Zhang,Xiran Zhang,Ting Cai,Sijia Shao,Biao Huang,Yi Zhang,Zhigang Hu,Liang Wang,Xiaobin Liu
DOI: https://doi.org/10.1016/j.ekir.2024.02.238
IF: 6.234
2024-01-01
Kidney International Reports
Abstract:M-type phospholipase A2 receptor(PLA2R) is a major autoantigen of primary membranous nephropathy(PMN) and anti-PLA2R antibody levels are closely associated with disease severity and therapeutic effectiveness.With the investigation of the immunological epitopes of the PLA2R antigen,the knowledge of the immunological pathogenesis of PMN has been deepened.As the analysis of epitope reactivity may have a predictive value greater than that of PLA2R-antibody level,our study aimed to discover the relationship between domain specific antibody levels and clinical outcome of patients with PMN.
What problem does this paper attempt to address?